Search

everythinglearnresearchcommunity

for

Search:↓

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Minoxidil and Finasteride are the most popular hair loss treatments, with rising interest in other options, and economic or health crises can change what treatments people prefer.

Optimal long-acting finasteride injection dose found: 16.8 mg, effective for one month.

Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.

PRP injections effectively promote hair growth in androgenetic alopecia patients.

Finasteride doesn't change rat testicle weight or sperm production.

Finasteride changes antioxidant enzyme expression, possibly affecting sperm protection in rats.

Finasteride causes harmful organ changes in female mice.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Finasteride and dutasteride effectively stop or reverse hair loss in women with androgenetic alopecia, with dutasteride being more effective for women under 50.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

AGA treated with finasteride, minoxidil, and hair transplantation.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Nanotechnology shows promise for better drug delivery and cancer treatment.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Finasteride improves heart function in obese and aging male rats by reducing oxidative stress and p53 protein levels.

Combining micro-needling, LED therapy, and growth factors with Finasteride® significantly improves hair growth.

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

Finasteride significantly reduces DHT levels in male dogs without affecting testosterone levels, suggesting it could be used to treat benign prostatic hypertrophy in dogs weighing 10 to 50 kilograms.

Higher serum androgens contribute to male pattern baldness.

Lowering certain hormone levels improves treatment for hair loss in young men.

Men with male pattern baldness don't necessarily have high levels of Dehydroepyandrosterone-sulfate, and there's no link between its levels and the severity of hair loss.

Men with hair loss don't necessarily have higher levels of the hormone DHEA-S, but this hormone tends to decrease with age.